Oncopeptides Ab Is A Biotechnology Company Based In Stockholmfounded In 2000 By Prominent Swedish Cancer Researchersthe Company Focuses On Developing Targeted Therapies For Hematological Cancersparticularly Relapsed And Refractory Multiple Myelomait Operates In Swedengermanyand The U S Utilizing Proprietary Platforms To Improve Drug Delivery And Effectiveness One Of Its Key Products Is Pepaxtia Melphalan Flufenamide A Peptide Drug Conjugate Approved In Europe For Treating Multiple Myelomathe Company Is Also Advancing Opd5A Pipeline Molecule Under Review By The U Sfdaoncopeptides Has A Robust Research And Development Programwith Over 16 Clinical Trials And More Than Six Drugs In Developmentemphasizing Alkylating Agents And Targeted Therapiesthe Company Has Established A Commercial Presence In Key European Markets And Is Exploring Strategic Partnerships To Expand Its Reach
No conferences found for this company.
| Company Name | Oncopeptides Ab |
| Country |
Sweden
|
| Address | N/A |
| Telephone | N/A |
| N/A |
